More than 14,000 packs of cold and flu medicine have been recalled in the United States because they could pose a poisoning risk to children.
The U.S. Consumer Product Safety Commission (CPSC) announced the recall on Thursday. It affects Safetussin Max Strength Multi-Symptom Cough, Cold and Flu tablets sold in blister packs. The packaging does not meet the standards of the Poison Prevention Packaging Act, which requires child-resistant packaging. The tablets can be pushed through the foil, making it easier for children to access and swallow them. This could lead to poisoning.
The CPSC said about 14,250 packs are included in the recall. So far, no injuries or incidents have been reported.
Details of the Recalled Product
The recall involves Safetussin Max Strength Multi-Symptom Cough, Cold and Flu 24-count caplet blister packs. The packs are marked with the words “Multi-Symptom,” “Cough, Cold & Flu,” and “Safe for adults with High Blood Pressure, Diabetes.” They come in cardboard boxes colored blue, orange, and red. Each box sold for about $11.
Where the Medicine Was Sold
The recalled medicine was sold at H-E-B, Harris Teeter, and other regional grocery stores and independent pharmacies across the country. Sales took place between July 2024 and March 2025. The tablets were made in India and distributed by Kramer Laboratories, based in Bridgewater, New Jersey.
What Consumers Should Do
Anyone who has this medicine should store it out of the reach of children right away. Consumers should contact Kramer Laboratories for guidance on how to return or dispose of the product safely. You can call 800-824-4894 Monday through Friday between 8 a.m. and 5 p.m. ET, email [email protected], or visit safetussin.com/recall for more information.
Related topics:
